Janssen Announces Phase 3 Pivotal Study Results for Darunavir-Based Complete Treatment Regimen
PARIS--(BUSINESS WIRE)--Janssen-Cilag International NV (Janssen) today announced that an investigational single-tablet regimen (STR) containing darunavir is effective and well tolerated. Results fr......